The cellular bases of antibody responses during dengue virus infection

The cellular bases of antibody responses during dengue virus infection

Dengue virus (DENV) is one of the most significant human viral pathogens transmitted by mosquitoes and can cause from an asymptomatic disease to mild undifferentiated fever, classical dengue, and severe dengue. Neutralizing memory antibody (Ab) responses are one of the most important mechanisms that...

Full description

Bibliographic Details
Main Authors:	Juan Carlos Yam-Puc, Leticia eCedillo-Barrón, Elsa Maribel Aguilar-Medina, Rosalío eRamos-Payán, Alejandro eEscobar-Gutiérrez, Leopoldo eFlores-Romo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-06-01
Series:	Frontiers in Immunology
Subjects:	Antibodies Dengue Virus Plasma Cells memory B cells in vivo B cell responses
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00218/full

Similar Items

Detection, phenotyping and quantification of dengue virus-specific B cells using fluorescent probes
by: Heather Friberg, et al.
Published: (2017-12-01)

The Chosen Few: Only a Subset of Memory B Cells Responds to Secondary Dengue Virus Infections
by: Deepta Bhattacharya, et al.
Published: (2016-10-01)

Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection
by: Vinit Upasani, et al.
Published: (2019-10-01)

Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool
by: Ramapraba Appanna, et al.
Published: (2016-10-01)

Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for one year after infection
by: Ying Xiu eToh, et al.
Published: (2014-08-01)

Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand
by: Luis A. Sánchez-Vargas, et al.
Published: (2019-06-01)

The Janus face of proliferating plasmablasts in dengue and COVID-19 infections
by: Priya Nayak, et al.
Published: (2023-08-01)

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
by: Natasha D Durham, et al.
Published: (2019-12-01)

B1b cells recognize protective antigens after natural infection and vaccination
by: Adam eCunningham, et al.
Published: (2014-10-01)

Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development
by: Kulkanya Chokephaibulkit, et al.
Published: (2020-11-01)

In silico quantitative prediction of B-cell epitope
by: Raúl Isea
Published: (2015-11-01)

Origin and function of circulating plasmablasts during acute viral infections
by: Katja eFink
Published: (2012-04-01)

Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques
by: Tulika Singh, et al.
Published: (2024-03-01)

Editorial: Trends in dengue evolution, immune pathogenesis, and pathology
by: S Gowri Sankar, et al.
Published: (2023-05-01)

Crosstalk Between Dermal Fibroblasts and Dendritic Cells During Dengue Virus Infection
by: Alfredo E. Montes-Gómez, et al.
Published: (2020-10-01)

Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection
by: Zoe L. Lyski, et al.
Published: (2019-06-01)

In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines
by: Lyn Marielle I. Abesamis, et al.
Published: (2022-08-01)

Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1–TLR4-Dependent Mechanism
by: Carlos Alonso Domínguez-Alemán, et al.
Published: (2021-06-01)

Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-κB and Induction of Antiviral Response in Epithelial Cells
by: Meenakshi Kar, et al.
Published: (2019-10-01)

Low antibody titers five years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
by: Velumani, Sumathy, et al.
Published: (2016)

Direct Infection of B Cells by Dengue Virus Modulates B Cell Responses in a Cambodian Pediatric Cohort
by: Vinit Upasani, et al.
Published: (2021-02-01)

Human B1 cell Frequency: Isolation and Analysis of Human B1 Cells
by: Daniel eGriffin, et al.
Published: (2012-05-01)

Potential of stem cell therapy during dengue infection in mice
by: Maideensa Syed Gulam, Sakinah
Published: (2017)

Pathogenesis of Dengue viral infections
by: Gathsaurie Neelika Malavige, et al.
Published: (2011-07-01)

AGE-DEPENDENT FEATURES OF EVOLVING HUMORAL IMMUNITY IN CHILDREN
by: A. P. Toptygina, et al.
Published: (2014-07-01)

Efficacy of geraniin on dengue virus type-2 infected BALB/c mice
by: Siti Aisyah Abdul Ahmad, et al.
Published: (2019-02-01)

Dendritic Cell Apoptosis and the Pathogenesis of Dengue
by: Lysangela R. Alves, et al.
Published: (2012-11-01)

Dengue fever as a potential cause of sickle cell intrahepatic cholestasis: A report of two cases
by: Leonardo Rodrigues de Oliveira, et al.
Published: (2021-07-01)

Human T Cell Response to Dengue Virus Infection
by: Yuan Tian, et al.
Published: (2019-09-01)

B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients
by: Víctor A. Sosa-Hernández, et al.
Published: (2020-12-01)

Editorial: New Insights Into B Cell Subsets in Health and Disease
by: Veerle Somers, et al.
Published: (2022-02-01)

Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients
by: Dao Huy Manh, et al.
Published: (2020-09-01)

Mobilization of Hematopoietic Stem and Progenitor Cells during Dengue Virus Infection
by: Irwin Puc, et al.
Published: (2022-11-01)

Protective Immune Response to Dengue Virus Infection and Vaccines: perspectives from the field to the bench
by: Scott B Halstead, et al.
Published: (2015-02-01)

Cytotoxic effect of Montivipera bornmuelleri’s venom on cancer cell lines: in vitro and in vivo studies
by: Carol Haddoub, et al.
Published: (2020-10-01)

Single-Cell Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways
by: Alexander Stewart, et al.
Published: (2021-03-01)

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial
by: Juliana Park, et al.
Published: (2021-07-01)

Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors
by: Sharton V. A. Coelho, et al.
Published: (2021-01-01)

Factors Regulating Immunoglobulin Production by Normal and Disease-Associated Plasma Cells
by: David A. Jackson, et al.
Published: (2015-01-01)

Effect of dengue hemorrhagic fever on thrombomodulin level
by: Hendra Widjaja, et al.
Published: (2009-10-01)